Methylated and Unmethylated pDNA Delivery Comparison in Mammalian Cells by Meraji, Seyedehmelika (Author) et al.
Methylated and Unmethylated pDNA Delivery Comparison in Mammalian Cells
by
Seyedehmelika Meraji
A Thesis Presented in Partial Fulfillment
of the Requirements for the Degree
Master of Science
Approved April 2018 by the
Graduate Supervisory Committee:
Kaushal Rege, Chair
Brent Nannenga
Matthew Green
ARIZONA STATE UNIVERSITY
May 2018
ABSTRACT
In this study, the differences in delivery of methylated and unmethylated prokary-
otic DNA in mammalian cells was investigated. 3 plasmids, DH5-α, ER2925 and
GM272 were extracted and transformed from E. coli bacteria. DH5-α is the regular
methylated plasmid, however,ER2925 and GM272 lack Dam and Dcm enzymes which
methylate adenine and internal cytosine in prokaryotes respectively, hence they are
unmethylated. The 3 plasmids were delivered via different delivery vectors in two
cell lines, UMUC3 and MDA-MB-231 which are human bladder cancer cell line and
human triple negative breast cancer cell line, respectively.
Luciferase and BCA assay were carried out to quantify transgene expression to
compare the efficacy of gene delivery in three aforementioned plasmids. In addition,
hydrodynamic diameter and zeta potential was measured for all delivery vectors, to
correlate with other transgene expression data. The results show that methylated
plasmid has significantly higher transgene expression in mammalian cell lines. This
can be either a result of smaller size and more positive zeta potential that the methy-
lated plasmid had, or a result of having Dam and Dcm enzymes which enhance binding
of DNA and transcription factors and enhance gene expression. Having smaller size
and more positive zeta potential was proven to be the case for the methylated plasmid
in this study. However the latter hypothesis should be investigated furthermore.
i
ACKNOWLEDGMENTS
I would like to first thank my advisor, Dr. Rege who gave me the opportunity to
do research in his lab and helped me through this project. I would like to thank Dr.
Matt Christensen, Dr. Sheba Goklany, Dr. Sudhakar Godeshala and soon to be Dr.
Rajesh Niti for teaching me almost everything I know about how to do research.
I like to thank my parents who called me every single morning in the past 2.5
years that I’ve been away and supported me financially and emotionally.
Monireh, Yasi and Taraneh, who brought light into my life.
And finally I would like to Thank Peyman, without whom I would never been
able to go through this journey. You were there for me at all times and I’m forever
grateful.
ii
TABLE OF CONTENTS
Page
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . iv
LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
CHAPTER
1 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.1 Gene Delivery . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
1.2 Intercellular Barriers for Non-viral Gene Delivery . . . . . . . . . . . . . . . . . 3
1.2.1 Cellular Uptake and its Barriers . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
1.2.2 Endosomal Escape . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6
1.2.3 Nuclear Entry . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.2.4 Delivery Vector Dissociation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7
1.3 DNA and Histone Modification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.3.1 Histone Modification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
1.3.2 DNA Methylation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
2 PREPARATION, TESTING METHODS AND RESULTS . . . . . . . . . . . . . . 14
2.1 Methodology . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.1.1 Materials . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.1.2 Preparation and Testing Methods . . . . . . . . . . . . . . . . . . . . . . . . . 14
2.2 Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
3 CONCLUSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35
REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
iii
LIST OF TABLES
Table Page
1.1 Examples of Loci Under Dam Methylation Control in Gamma-proteobacteria
Sa´nchez-Romero et al. (2015) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
iv
LIST OF FIGURES
Figure Page
1.1 Intercellular Barriers to Gene Delivery Christensen (2016) Used with
Permission . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4
2.1 Plasmid pGL4.5 Schematics (sketched Using SnapGene Software). . . . . . 15
2.2 Polymer Monomers Potta et al. (2014) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
2.3 LUV
µgofProtein
for Each Plasmid-PG Polymer Polyplex Was Measured in
UMUC3 and MDA-MB-231 Cell Lines . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
2.4 LUV
µgofProtein
for Each Plasmid-PGC18 (1:5) Lipopolymer Polyplex Was
Measured in UMUC3 and MDA-MB-231 Cell Lines . . . . . . . . . . . . . . . . . . . 23
2.5 Log LUV
µgofProtein
for Each Plasmid-NR Polymer Polyplex Was Measured
in UMUC3 and MDA-MB-231 Cell Lines . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
2.6 Viability Was Measured for Each Condition in Both Cell Lines . . . . . . . . 25
2.7 Hydrodynamic Diameter and Zeta Potential of Each Plasmid-PG Poly-
mer Polyplex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26
2.8 Hydrodynamic Diameter and Zeta Potential of Each Plasmid-PGC18
(1:5) Lipopolymer Polyplex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27
2.9 Hydrodynamic Diameter and Zeta Potential of Each Plasmid-NR Poly-
mer Polyplex . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
2.10 Hydrodynamic Diameters and Zeta Potentials of 3 Polymers . . . . . . . . . . 29
2.11 Hydrodynamic Diameters and Zeta Potentials of 3 Plasmids . . . . . . . . . . 30
v
Chapter 1
INTRODUCTION
1.1 Gene Delivery
Gene delivery is the process of transferring exogenous nucleic acid into the host cell
nucleus.It has several applications including expression of therapeutic proteins, gene
therapy, and is a technique to understand biological pathways Christensen (2016).
These applications are discussed below.
Gene delivery can be used to employ the cells to produce recombinant proteins in
large scale for downstream use. These proteins can be used directly as therapeutics
or in protein vaccines Jin et al. (2014); Baldi et al. (2007). Potential treatment
of several genetic disorders, either inherited or acquired, is now considerable by gene
therapy. Cancer, AIDS and cardiovascular disease are some examples of such deceases.
The principle that this approach is based on, is to deliver the foreign DNA to alter
defective gene expression at the origin of the defect. This alteration is done with two
approaches. The first approach is to correct the genetic malfunctions and ultimately
rescue the cell and the organ. The second approach though, leads the host cells to
self destruction. This approach is mainly used in cancer gene therapy. The advantage
of gene therapy against others is that the limitations of some protein drugs can be
bypassed with this technique Jin et al. (2014); Liu and Huang (2002); Christensen
(2016); Siu et al. (2012). In molecular biology, in vitro gene delivery is used as a study
tool to study biological pathways. For example, it is used to study gene functions via
manipulative protein expression. Silencing a specific gene ,which can be carried out
by delivering siRNA or shRNA, can help us determine specific protein functions Jin
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et al. (2014); Christensen (2016).
There are many intercellular barriers to nucleic acid transfer that are thoroughly
discussed in the next section. However, in this section, we talk about two methods
that are employed to circumvent the intercellular barriers. Gene delivery methods
should ideally have high transfection efficiency and low toxicity to the cells Jin et al.
(2014). Currently, three main categories of gene delivery methods are employed. viral
vector based, non-viral vector based and physical Mali (2013).
Virus vectors are either replication-deficient viruses, which contain our nucleic
acid of interest but the decease causing sequence is deleted from their genome,or
genetically modified viruses Kamimura et al. (2011); Mali (2013).
Non-viral gene delivery methods are done using natural or synthetic compounds
to bound with DNA and form a complex with it. Complexes of DNA with protein,
lipids and polymers are examples of non-viral vectors Kamimura et al. (2011); Mali
(2013). Usually, the transgene expression of the plasmids delivered via cationic vectors
have two phases. In the first few days the transgene expression is dramatically high
and after that transgene expression continues at a lower intensity Al-Dosari and Gao
(2009). This can be due to several reasons. Most of the times, the transfered plasmid
stays in the cell nucleus episomal DNA molecule and do not integrate with the target
cell’s genomic DNA. During cell division, these plasmids are not replicated and as
the population percentage of newly divided cells grow and old cells die, transgene
expression lowers. Another reason for this decline in transgene expression may be the
programmed death of transfected cells or that the transfected cells simply die because
of the injuries caused by tansfection Nguyen et al. (2007). In addition, transfected
cells may be eliminated due to the immune response to producing foreign proteins
Wolff et al. (1992).
Physical methods focuses on overcoming membrane and intercellular barriers us-
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ing physical principles. For examples, one of the physical methods is to inject the
DNA directly to the target tissue with a needle. Injection into muscle cells, skin,
cardiac muscle, liver and solid tumor had been successfully done. Some other are
Electroporation, Sonoporation, Photoporation, Photoporation, etcKamimura et al.
(2011); Mali (2013).
All these methods have their advantages and disadvantages in comparison to one
another. Virus vectors are the most efficient, however there are some safety issues
with them and they are very costly as well. Non-viral vectors are much less toxic than
the viral vectors. Another advantage of them is that they are more likely to be used
for delivering long nucleic acid sequences and they are less immunogenic. Advantage
of physical methods in comparison to the two methods previously mentioned is its
simplicity since DNA is delivered straightly to the target without the usage of other
substances which can be toxic to the cell or immunogenic and is the method utilized
in DNA vaccination. In addition, non-endocytic strategies such as microinjection
and electroporation allow the nucleic acid to circumvent many intercellular barriers
such as escaping the endocytic vesicles. However, the disadvantages of this method
is its low efficiency and the fact that gene delivery is only restricted to the injected
cells. Thus their application is limited in gene therapy and industrial scale protein
production Kamimura et al. (2011); Mali (2013); Christensen (2016).
Some advantages and disadvantages and characteristics of different non-viral meth-
ods are listed in the table below:
1.2 Intercellular Barriers for Non-viral Gene Delivery
There are many intercellular barriers that gene delivery vectors should circumvent
for a successful transfection. They are demonstrated in 1.1 and in the following
subsections, we will discuss them in detail.
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Figure 1.1: Intercellular Barriers to Gene Delivery Christensen (2016) Used with
Permission
1.2.1 Cellular Uptake and its Barriers
In encodytic cellular uptake, the cargo can enter the cell via four different path-
ways, clathrin-mediated endocytosis, caveolae, phagocytosis and macropinocytosis.
Size and surface charge of the cargo have a huge impact on cellular uptake as well as
the cell itself. Moreover, multiple mechanisms may occur simultaneously due to the
heterogeneity of the cargoes.
Clathrin-mediated Endocytosis
Clathrin-mediated endocytosis is mediated by a large protein named Clathrin. On
the inner surface of the cell plasma membrane, a coated pit is formed with the help
of this protein. The ligands of this protein complex bind to the plasma membrane
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receptors and lipids and clatherin forms a coat around the cargoIrajizad et al. (2017).
Then from this pit the cargo comes into the cytoplasm of the cell as a coated vesicle.
Later, the vesicles lose their clatherin coating. the fusion a similar vesicles ultimately
form early endosomes DeB (1998); Christensen (2016).
Caveolaes
Caveolaes are cave like structures in the membrane. Many cell types have caveolaes
on their surface and they can take up to a third of plasma membrane surface. The
pits are relatively narrow with a diameter of approximately 50 nm. They consist of
a cholesterol binding protein called Vip21 and a bilayer of cholesterol and glycolipids
Christensen (2016). cellular uptake is mediated via receptors in caveolaes however
it’s clatherin independent. Unlike clatherin mediated uptake which the vesicles then
goes to form an early endosome, the cargo taken up via cavolaes can go directly to
Golgi or endoplasmic reticulum for sorting. As a result, they bypass the pathway in
which are lead to degradation by lysosome which can affect the delivery of nucleic
acid’s efficacy Parton and Simons (2007).
Phagocytosis
Phagocytosis, is the cellular uptake pathway most commonly used by the immune
system cells to take up pathogens and other large particles (larger than 500 nm in
diameter)Christensen (2016). Phagocytosis can also occur in cells other than immune
system cells and has the potential to be used for delivery of particles that are too large
to be taken up by caveolaes or clatherin mediated pathways. Despite its applications
in gene delivery, for in vivo gene delivery, phagocytic cells in the immune system
might take up the delivered nucleic acid in the blood and affect gene delivery efficacy
Dash et al. (1999). The takeup vesicle with this pathway is called phagosome. It’s
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ultimately lead to fusion with lysosome for degredation Falcone et al. (2006).
Macropinocytosis
Macropinocytosis is another pathway of cellular uptake. This pathway involves uptake
of large particles which results in 500-5000 nm vesicle diameter. Another difference
of this pathway in comparison to caveolae and clatherin mediated is that no receptors
are involved. The vesicle later forms early endosomesFalcone et al. (2006).
Delivery vectors can be taken up and trafficked in the cells in via different path-
ways. Even subtle differences in delivery vectors can change the pathway in which the
cargo is taken up. The hydrodynamic diameter of the cargo its surface charges have
tremendous effects on cellular take-up. For example, a study shows that in murine
melanoma cell line, different cellular take-up pathways were utilized depending on
the size of the latex bead cargoes. Cargoes smaller than 200 nm in diameter were
taken up via clatherin mediated pathway. However, cargoes larger than 500 nm were
taken up by caveolae. Since in caveolae takeup, the cargo circumvents degradation
by lysosomes, it can be relatively more efficient in this case Christensen (2016).
1.2.2 Endosomal Escape
Sorting endocytosed materials before they are degraded by lysosomes are done by
endosomes. Internalized cargoes from the plasma membrane can either go to lyso-
some for degradation or be recycled back to the plasma membrane. Depending on
the stage after endocytosis, endosomes are classified as early, sorting, or late endo-
somes. Different stages of endosomes have different mythologies. Early endosomes
have tubules however late endosomes mostly don’t and are spherical. This is due to
early endosome’s loss of tubules to recycling pathways back to the plasma membrane
Barua and Rege (2009). Endocytic vesicles fuse into early endosomes after being un-
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coated. Later, early endosomes mature into late endosomes and ultimately fuse with
lysosomes. In the stage of maturation of early endosomes into late endosomes, the
pH level lowers. The drop in pH level can assist endosomal escape for gene delivery
before endosomal maturation and ultimately fusion with lysosome Mellman (1996);
Suh et al. (2003).
1.2.3 Nuclear Entry
After overcoming the barriers discussed before, cargo has to enter the cell nucleus.
As we know, The nucleus of the cell is constantly dividing due to cell division. The
Nucleus membrane of a dividing cell is much more permeable than a non-dividing
nucleus due to the nuclear membrane breakdown prior to cell division. As a result,
cargo can relatively easily penetrate dividing nuclei where as it is almost impossible
for it to enter the nucleus at any other time Jones and Takai (2001). Diffusion through
cell nucleus pore complexes only allows particles smaller than 9 nm to penetrate a
non-dividing cell nuclei. To summarize, this step of gene delivery is relatively much
more inefficient for non-viral gene delivery vehicles Christensen (2016); van der Aa
et al. (2006).
1.2.4 Delivery Vector Dissociation
When designing gene delivery vectors, we must take into account that this step
works against the previous ones. For gene transfer into the nucleus, the binding of the
nucleic acid and delivery vector should be strong. However, in this step DNA should
unbind with the delivery vector for it to be accessible to the host cell’s transcription
machinery Huth et al. (2006); Schaffer et al. (2000). Cationic carrier has can be
removed from the exogenous nucleic acid by the chromosomal DNA in the nucleus in
this step. However, removal of the cationic carrier of delivery vector in the cytoplasm
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by host cell RNA can make gene delivery more inefficient Christensen (2016); Kircheis
et al. (2001).
1.3 DNA and Histone Modification
1.3.1 Histone Modification
In eukaryotic cells, DNA is wrapped around some alkaline proteins called histone.
The structural units that DNA and histone make are called nucleosomes. Histone
not only orders the DNA into structural nucloesomes, but has other roles specially in
gene expression regulations which affects whether a gene is activated or repressed due
to the interactions between DNA and histone tails. These interactions result from
the bounds between histone and DNA getting tighter or looser. Histone proteins
have tails that can be covalently modified. Some of the most important covalent
modifications are acetylation and methylation. Acetylation has an activation role for
genes. However, methylation can have either activation or repression role depending
which histone tail is activated and how many methyl groups are attached to the
histone tails. These modifications do not make a change in genomic DNA sequence.
Delpu et al. (2013)
1.3.2 DNA Methylation
DNA Methylation in Eukaryotes
DNA methylation is very abundant in eukaryotic systems, specially in plants and
vertebrates. Methyl groups are added to DNA at two times. First, they can be added
to newly replicated DNA. Modification in methylation pattern, can later be carried
out by adding and removing methyl groups from various sites. Methylation pattern
in cancer cells is very different from normal ones as it is largely modified in them.
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This difference can be used to distinguish cancer cells. Delpu et al. (2013); Schu¨beler
(2015)
Methylation is carried out by the enzyme methyl transferase. For DNA methy-
lation, the enzyme is called DNA methyl transferase (DNMT). DNA methylation
sites are very specific. CpG islands in plants and vertebrates are mostly located near
the promoter of the genes. They provide many DNA methylation sites since they
are usually about 1000-2000 base pairs long Klose and Bird (2006); Jones and Takai
(2001).
Usually, the activity of DNA methylation is to silence genes and inhibit their
transcription long term. This regulatory action is specially done in tissue specific
genes. These genes help our tissues have different functions despite the genomic
DNA being the same in all of them. Tissue specific gene silencing helps prevent genes
to be expressed in the wrong tissue Bird (2002).
DNA methylation, inhibits gene transcription in two ways. First, for the initia-
tion of the transcription, activator proteins are transcription factors that bind to the
enhancer sequence present behind the promoter of the gene to be transcribed. In
eukaryotic system, transcription factors play an important role in initiation of tran-
scription. In normal situation, the activator protein attaches to the enhancer sequence
and will send some signal which will recruit the polymerase and the transcription will
go on Li et al. (1993); Jones and Takai (2001). However, due to methylation in the
CpG island, the activator protein can no longer bind to the enhancer element. As a
result, the activator protein can no longer provide any signal to call upon the poly-
merase. Hence the transcription will not take place Klose and Bird (2006); Razin
(1984).
The second way that DNA methylation can inhibit transcription in by a protein
known as ”methyl CpG binding protein” (MBD). This protein binds to methylated
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sequencesBird (2002). These proteins are recruited to the methylated sites in DNA
and attach to them by covalent binds. As a result, activator protein cannot bind to
the DNA. So the transcription will not be initiated. This kind of MBD attachment
will recruit Histone Deacetylase (HDAC) protein to detach the acetyl group from the
histone and further inhibit gene transcription Li et al. (1993); Razin (1984).
DNA Methylation in Prokaryotes
Similar to eukaryotes, DNA methylation plays important roles in prokaryotes and is
specially very prevalent among prokaryotes. Using single molecule, real-time sequenc-
ing (SMRs) to map DNA modifications for 230 diverse bacterial and archaeal species,
DNA methylation was found in 93% of them. In that study, 840 distinct methylated
motifs and 620 620 DNA Methyltransferases binding sites were found leading to ac-
knowledge diverse presence and functions of DNA methylation in prokaryotes Blow
et al. (2016). Along with m5C (C5-Methyl-cytosine) which is most prevelant in eu-
karyotes, m6A (N6-methyl-adenine) and m4C (N4-methyl-cytosine) are also found in
bacteria. m6A is also found in lower eukarytes (not in vertebrates) but m4C is only
found in bacteria Sa´nchez-Romero et al. (2015). Despite the abundance, patterns and
functions of methylation in prokaryotic DNA is still relatively unknown.
DNA methylation along with restriction enzymes are components of restriction-
modification (RM) systems. The main function of this system is to protect the
integrity of prokaryotic genome. For example, they are linked to DNA base pair
mismatch repair. In addition, restriction endonuclease degrades DNA from exoge-
nous sources (eg. viruses) while methyl transferase binds to restriction endonuclease
sites in the host genome to prevent cleavage Blow et al. (2016); Modrich and Lahue
(1996); Sa´nchez-Romero et al. (2015). To further study RM systems in prokaryotes,
a comprehensive database of restriction enzymes, DNA methyl transferases and other
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proteins involved in the process has been gathered. This database is refereed as
”REBASE” Roberts et al. (2010).
As mentioned before, DNA methylation has an important role in eukaryotic genome
regulation. However, its role in prokaryotic genome regulation and the extent of it
is still relatively unknown. What we know is that in prokaryotes, if a regulatory
region (eg pomoter region) is methylated, the methyl groups can help binding of
transcription factors (eg RNA polymerase) with cell DNA. Some examples of such
regulation involves two methyltransferase enzymes Dam (Deoxyadenosine methylase)
and CcrM (cell-cycle regulated methyltransferase). These enzymes both methylate
adenine bases in DNA and if they methylate DNA at a regulatory region (eg pro-
moter region), they can regulate transcription. Methylation-dependent transcription
controls are divided into two groups: Clock-like and Switch-like controls. In clock-
like controls, gene methylation (which activates expression) is linked to the stage
of the cell cycle. However, switch-like controls work in a different manner. Before
DNA methylation patterns are formed, they turn on and off gene methylation, hence
gene expression Sa´nchez-Romero et al. (2015); Han et al. (2004). Some examples of
Dam methylation control in Gamma-proteobacteria -which E. coli is a part of- are
mentioned in the table 1.1.
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Table 1.1: Examples of Loci Under Dam Methylation Control in Gamma-
proteobacteria Sa´nchez-Romero et al. (2015)
Like adenine methylation, cytosine methylation in prokaryotes also have regula-
tory effects on transcription, like enhancement. Inoue et al. (1997) However, unlike
adenine methylation which typically enhances transcription, cytosine methylation can
have both enhancement and repression effect Militello et al. (2014). two studies on E.
coli suggest that lack of Dcm (DNA cytosine methyltransferase) increased expression
of stress response sigma factor RpoS and drug resistance transporter SugE. However,
relationship between m5C and transcription is not yet fully known. In these studies,
Dcm did not have an effect on E. coli growth rate or the ability to enter or persist
stationary phase Kahramanoglou et al. (2012); Sa´nchez-Romero et al. (2015).
Plasmid Methylation and Immune System Response
Since plasmid DNA is from a prokaryotic source, it is considered a foreign entity in
mammalian cells Yew (2005); McLachlan et al. (2000). As mentioned in the previous
sections, mammalian DNA have very abundant methylated CpG sequences. Since
CpG sequences are mostly unmethylated in prokaryotic DNA compared to mam-
malian DNA, the mammalian innate immune system recognizes the plasmid DNA.
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Krieg (1999); Reyes-Sandoval and Ertl (2004); Li and Huang (2000) As a result,
following the administration of polyplexes, an inflammatory response occurs. Un-
methylated CpG sequences activate a receptor called ”Toll-like receptor 9” which
then activated immune response from the cell ??Reyes-Sandoval and Ertl (2004).
Another reason for this immune system response may be due to the non-linear nature
of plasmids which again distinguish them from mammalian DNA Yew (2005); Zhou
et al. (2004). There are ways that we can reduce this immune response from the cell
in order to increase the efficiency of pDNA delivery. In a study it was shown that
the use of pDNA vectors which contain a reduced number of CpG motifs, results in a
reduction of inflammatory response. In that study, pDNAs were developed in a way
that all the CpG motifs from the enhancer, promoter, intron, poly- adenylation signal,
and antibiotic resistance gene were eliminated. The only remaining CpG sequences
were then found in plasmid replication origin which was about 20% of CpG sequences
in the original unmodified DNA. Delivery of this modified pDNA vector resulted in
a decrease in proinflammatory cytokines Yew et al. (2002).
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Chapter 2
PREPARATION, TESTING METHODS AND RESULTS
2.1 Methodology
2.1.1 Materials
dimethyl sulfoxide (DMSO), resorcinol diglycidyl ether (RDE) were purchased
from Sigma-Aldrich, St. Louis, USA. Aminoglycoside monomers, neomycin sulphate,
and paromomycin sulphate were purchased from Gold Biotechnology, Inc., USA. The
BCA protein assay kit was purchased from Thermo Scientific, Inc. (Rockford, IL).
The pGL4.5 control vector, which encodes for modified firefly luciferase protein under
the control of an SV promoter, and the Bright-GloTM luciferase assay system were
purchased from Promega Corporation (Madison, WI). acetone was purchased from
VWR international LLC, USA suppliers and was used without further purification.
MDA-MB-231 human triple-negative breast cancer cells, and UMUC3 human bladder
cancer cells were procured from the American Type Cell Culture (Manassas, VA).
2.1.2 Preparation and Testing Methods
Bacterial Transformation and Preparation of Plasmids
Plasmid pGL4.5 was used for this study. A schematic of this plasmid is shown in
??. This plasmid codes for Luc2 gene which is the firefly luciferase. Hygromycin
resistance gene is used as a biological marker in this plasmid. The plasmid has a
replication origin after the hygromycin resistance gene and also codes for ampicillin
resistance gene in order to survive after adding ampicilin to its media. Ampicillin is
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added to the media in order to eliminate all the other microorganisms in the media
and only our bacteria of interest which contains ampicillin resistance gene can survive.
Figure 2.1: Plasmid pGL4.5 Schematics (sketched Using SnapGene Software)
For this study, 3 variations of plasmid DNA pGL4.5 were prepared: DH5-α, K12
ER2925 and GM272. K12 ER2925 lacks Dam5 and GM272 lacks Dam3 and Dcm6 en-
zymes which as previously discussed, methylate adenine and cytosine bases in prokary-
otic DNA MacNeil (1988); Sun et al. (2010). Hence, These strains are relatively un-
methylated. On the contrary, DH5-α is the regular methylated pGL4.5 strain. Dam
enzyme methylates Adenine in GATC sequences and Dcm enzyme methylates the
second cytosine in CCAGG and CCTGG sequences. In pGL4.5 plasmid, there are
17 GATC and 12 CCWGG sequences in luc2 gene and its promoter. In the whole
plasmid, there are 34 GATC and 20 CCWGG sequences respectively.
Bacterial transformation of pDNA pGL4.5 was carried out in order to prepare
ER2925 and GM272 E. coli strains. For this process, 2 µl of pGL4.5 with concen-
tration of 150ng
µl
was mixed with 20 µl of component cells. The mixture was then
incubated on ice for 20 minutes. For the heat shock, mixture was put in 42◦C water
bath for 45 seconds and then incubated on ice for an additional 3 minutes. 800 µl
LB media was added to the mixture and they were placed on a shaker at 37◦C ,200
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rpm for 3 hours. Then, cells were centrifuged for 1 minute at 10000 rcf. Most of
the supernatant was discarded, however, cells with the remaining supernatant were
plated on LB + Ampicillin (100 mg/L) agar plates. 24 hours later, the colonies had
grown. Individual colonies were injected in LB + Ampicillin (100 mg/L) liquid media
and were placed on shaker at 37◦C ,200 rpm for 24 hours. Plasmid DNA were then
extracted.
Competent E. coli strains were prepared using the Mix and Go E. coli Transfor-
mation Kit and Buffer Set and plasmid DNA extraction was done using the Qiagen
Plasmid Maxi Kit.
After extraction, plasmid DNA concentration and purity were determined using
a NanoDrop Spectrophotometer (ND-1000; NanoDrop Technologies) by measuring
absorbance at 260 and 280 nm. Plasmid stocks were made with concentration of 25ng
µl
in EB buffer (Qiagen, Germany) to make polyplexes in the future.
Polymers
PG and NR
The two polymers used in this project, paromomycinGDE(PG) and neomycinRDE(NR)(GDE:
Glycerol diglycidyl ether and RDE: Resorcinol diglycidyl ether) were synthesized by
Dr. Sudhakar Godeshala according to Godeshala et al. (2016). In short, a solution of
sulphate-containing aminoglycosides neomycin and paromomycin in nanopure water
was ion exchanged in a Cl-ion exchange resin for 3 hours. After the sulphates were
removed, the resultant aminoglycosides were reacted with GDE (in case of PG) or
RDE(in case of NR) in a solution containing 1:2.2 molar ratio of water and N,N-
dimethylformamide (DMF) ), (1.5:1 v/v) for 5 hours at 60C. Acetone was used to
precipitate the reaction mixture and further purification was carried out by dialysis
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using a 3.5 kDa molecular weight cutoff(MWCO) dialysis membrane for 48 hr to re-
move unreacted aminoglycosides and diglycidylethers. To obtain the purified polymer
after dialysis, the material was lyophilized. The MW values for these polymers are
4,889 and 3,965 respectivelyPotta et al. (2014). The monomers of these polymers are
shown in 2.2.
(a) GDE
(b) RDE
Figure 2.2: Polymer Monomers Potta et al. (2014)
PG-C18(1:5)
A solution of 0.01 mmol PG in 2ml DMSO was stirred at room temperature for 30
minutes, after which 0.1 mmol triethyl amine(TEA) was added to the solution, and
was stirred for an additional 30minutes. The solution was then cooled to 4◦C and
a 1:5 molar ratio of alkanoyl chloride (with respect to PG) was added in a dropwise
manner. The mixture was stirred at RT for 12 hours, then precipitated in excess ether,
dialyzed against water for 48 hours using a 3500 molecular weight cutoff (MWCO)
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membrane. To obtain the lipopolymer product, the dialyzed material was further
luophilized. he MW value for this lipopolymer is 4,519Miryala et al. (2015).
Gel Permeation Chromatography
Gel Permeation Chromatography (GPC) was used to measure the molecular weights
of PG, PG-C18(1:5) and NR. The system used was Waters 1515 GPC system, equipped
with an ultrahydrogel 250 column (Waters Corporation, MA) and a refractive index
detector (Waters 2410) with Waters Millennium 32 GPC software. A solution of 0.1%
trifloroacetic acid and 40mobile phase which was operated at 0.5 mL/min flow rate
and the temperature was set at 358C. Poly(2-vinyl- pyridine) standards (MWs: 3,300,
7,600, 12,800, 35,000, and 70,000Da) were employed for molecular weight (MW) cal-
ibration. To further investigate the MW range, purified samples after dialysis were
subjected to ninhydrin analysis which reports for reactive amine content. To deter-
mine the theamine content of the polymers, a calibration using glycine was carried
out, and the relative amounts of residual amines were compared to determine the
molecular weight range of the polymers Potta et al. (2014).
In order to make polyplexes for the experiments, polymer solution stocks were
prepared with concentration of 1.5mg
µl
in 1XPBS and were filtered through 2µm filters.
Cell Culture
UMUC3 and MDA-MB231 cells were cultured in DMEM media containing 10% v/v
fetal bovine serum (FBS) and 1% penicillin streptomycin (10,000 units/mL) solution
in an atmosphere of air (95%) and carbon dioxide (5%) in an incubator at 37 ◦C.
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Transgene Expression in Cells
When approximately 80% confluent, cells were trypsinized with 0.25% trypsin-EDTA
and plated in 96 well plates (Corning,Corning, NY, USA) with density of 10000
cells/well in DMEM media. Plates were incubated in previously mentioned situation
(Atmosphere: 95% air, 5% carbon dioxide at 37◦C) for 18-24 hours. Polyplexes
were prepared by adding the polymer solution to the DNA (with the following w/w
DNA:Polymer ratios: 1:4, 1:5, 1:10, 1:15, 1:20, 1:25, 1:50, 1:75, 1:100) and letting
them sit for 30 minutes at room temperature. Ployplexes were then added to each
well (75 ng of pDNA per well). Plates were then incubated in the previous situation
for 48 hours before screening to allow for transgene delivery and expression.
Luciferase and BCA Assay
48 hours after the transfection, media was removed from the cells and they were
washed with 1x PBS. After removing PBS, cell culture lysis reagent (Promega) was
added to the cells. Plates were incubated for 15 minutes in 37◦C for the cells to be
lysed. 30 µl of the luciferin solution (Bright GloTM Luciferase assay kit (Promega))
was added to 15 µl of cell lysate and luminescence (LUM) was immediately measured
using Synergy 2 plate reader (Biotek, Winooski, VT). Using the BCA Protein assay
kit (Pierce, Rockford, IL, USA), total protein content was determined from the cell
lysates .
Quantification of Luciferase Expression
For quantification, LUV values were determined by dividing luminescence values
(LUM) by relative cell proliferation (PRO). LUV values were normalized by the to-
tal protein content values from BCA assay. These normalized values (LUV/ µg of
protein) are used to compare different conditions.
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Cytotoxicity of Polyplexes
48 hours after the transfection is done (same time as the Luciferace assay), MTT assay
is carried out on the transfected cells to make sure that the polyplexes were not cyto-
toxic. 10 µl of MTT reagent ((3-(4,5-Dimethylthiazol-2-yl)22,5-diphenyltetrazolium
bromide)) was added to each well including the controls which are the untreated and
dead cells. Then the plate was incubated in the previous situation for 4 hours. Then,
the media was removed from the wells and 50 µl of 1:1 v/v solution of DMSO and
methanol were added to each well to dissolve remaining crystals. After being incu-
bated in room temperature for 30 minutes, the absorbance of each well at 570 nm and
670 nm was determined using the plate reader (Bio-Tek Synergy 2). Cell viability is
determined by the following formula:
%viability =
Awell−Adead
Alive−Adead
× 100
Awell=Aabsorbance at 570 - Aabsorbance at 670
Determination of Hydrodynamic Diameter and Zeta Potential
Polyplexes were prepared in a similar manner as previously mentioned in transfection
section. Size and zeta potential of the polyplexes were measured in triplicates using
a Zetasizer Nanosystems Nano-ZS instrument (Malvern Instruments, Mission Viejo,
CA).
For the size, 50 µl of polyplex diluted in 950 µl of 1xHEPES buffer (10 mM,
pH 7.4) were used for the measurements and For measuring zeta potentials, 50 µl of
polyplex diluted in 950 µl of 1xPBS (pH 7.4) were used for the measurements.
In addition to polyplexes, size and zeta potential of 3 plasmids and 3 polymers
were measured. Polymer and plasmid solutions were prepared with conc. of 75 µg
ml
in
1xHEPES buffer (10 mM, pH 7.4) and in 1xPBS (pH 7.4) and were used to measure
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size and zeta potential of them respectively.
All the measurements were done in room temperature.
Zeta potentials and size distribution measurements were carried out at least three
times after Polyplex formation. Positive charges on the surface of polymer and neg-
ative charges on the surface of DNA interact to form nanoscale polymer-DNA com-
plexes. Moreover, positively charged polyplexes can be delivered more efficiently.
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2.2 Results
Figure 2.3: LUV
µgofProtein
for Each Plasmid-PG Polymer Polyplex Was Measured in
UMUC3 and MDA-MB-231 Cell Lines
22
Figure 2.4: LUV
µgofProtein
for Each Plasmid-PGC18 (1:5) Lipopolymer Polyplex Was
Measured in UMUC3 and MDA-MB-231 Cell Lines
23
Figure 2.5: Log LUV
µgofProtein
for Each Plasmid-NR Polymer Polyplex Was Measured in
UMUC3 and MDA-MB-231 Cell Lines
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Figure 2.6: Viability Was Measured for Each Condition in Both Cell Lines
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(a) Hydrodynamic Diameter in 1xHEPES Buffer
(b) Zeta Potential in 1xPBS Buffer
Figure 2.7: Hydrodynamic Diameter and Zeta Potential of Each Plasmid-PG Polymer
Polyplex
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(a) Hydrodynamic Diameter in 1xHEPES Buffer
(b) Zeta Potential in 1xPBS Buffer
Figure 2.8: Hydrodynamic Diameter and Zeta Potential of Each Plasmid-PGC18
(1:5) Lipopolymer Polyplex
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(a) Hydrodynamic Diameter in 1xHEPES Buffer
(b) Zeta Potential in 1xPBS Buffer
Figure 2.9: Hydrodynamic Diameter and Zeta Potential of Each Plasmid-NR Polymer
Polyplex
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(a) Hydrodynamic Diameter in 1xHEPES Buffer
(b) Zeta Potential in 1xPBS Buffer
Figure 2.10: Hydrodynamic Diameters and Zeta Potentials of 3 Polymers
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(a) Hydrodynamic Diameter in 1xHEPES Buffer
(b) Zeta Potential in 1xPBS Buffer
Figure 2.11: Hydrodynamic Diameters and Zeta Potentials of 3 Plasmids
To quantify the difference of gene delivery between methylated and unmethylated
plasmids, transfections were carried out in 2 different cell lines, UMUC3 and MDA-
30
MB-231. The extent of expression of luciferase protein in each condition (different
cell line, carrier polymer, DNA:polymer weight ratio and different methylated and
unmethylated plasmids) determined how well the gene was delivered and transcribed.
To examine the first set of conditions, polyplexes were formed by slowly adding
different concentrations of PG polymer solution to three different plasmid solutions
(DH5-α, ER2925 and GM272) to make different weight ratio polyplexes. After adding
the polymer, the mixture is incubated for 30 minutes in room temperature for the
polyplexes to form. Different DNA:Polymer weight ratios tested were 1:10, 1:15, 1:20,
1:25, 1:50, 1:75, 1:100. Polyplexes were then added to UMUC3 and MDA-MB-231
cells for gene delivery.
figure 2.3 and show LUV
µgofProtein
for each plasmid-PG polyplex in UMUC3 and MDA-
MB-231 cell lines. As seen in figure 2.3 , in all conditions, the methylated plasmid
(DH5α) had considerably higher expression in comparison to the other two unmethy-
lated plasmids. Gene expression enhances as the DNA:Polymer increases at first and
then declines. The peak of transgene expression for DH5α and ER2925 plasmids are
in the 1:20 and 1:25 ratios in UMUC3 and MDA-MB-231 cell lines respectively. For
GM272 plasmid, the peak of expression is in 1:25 ratio in both cell lines.
Similarly, to examine the second set of conditions, polyplexes were formed using
the 3 plasmids and PGC18 (1:5) lipopolymer at DNA:Polymer weight ratios of 1:10,
1:15, 1:20, 1:25, 1:50, 1:75, 1:100. Figure 2.4show LUV
µgofProtein
for each plasmid-PGC18
(1:5) polyplex in UMUC3 and MDA-MB-231 cell lines. Similar to figure 2.3 the
methylated plasmid DH5α has significantly more expression than the other two un-
methylated plasmids. The peaks and trend are also the same where we see transgene
expression enhancement first and then it declines and the peaks are in 1:20-1:25 area.
Figure 2.5 shows LOG LUV
µgofProtein
for conditions of making plasmid-NR polyplex in
different DNA:Polymer weight ratios (1:4, 1:5, 1:7.5, 1:10, 1:20, 1:25, 1:50, 1:75, 1:100)
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in the 2 different cell lines, UMUC3 and MDA-MB-231. The scales of LUV
µgofProtein
for
the measurements in low DNA:Polymer ratios (1:4, 1:5, 1:7.5) were very different
from the rest of the values. In order to be able to see all the y-values and the trend,
y-axis in these graphs are plotted logarithmic. Staying consistent with the previous
two sets of conditions in figures 2.3 and 2.4, it shows the same peaks and trend were
we first see an increase in LUV
µgofProtein
and then it declines and the peak is around 1:20-
1:25 for all conditions. In addition, the methylated plasmid has significantly more
transgene expression in all the conditions than the other two unmethylated plasmids.
The reason why the DNA:Polymer weight ratios are different here in comparison to
PG and PGC18 (1:5) polymers is that according to figure 2.6 after 1:25 weight ratio,
the toxicity of the polyplex is too high and most likely affects the LUV
µgofProtein
values.
In order to be able to see an accurate trend, lower DNA:Polymer weight ratios were
used for experiments in addition to previous ones.
In conclusion, figures 2.3-2.5 all show the same trend where the methylated plas-
mid shows the highest transgene expression, hence the highest delivery with all three
polymers in both cell lines in comparison to the two unmethylated plasmids. Also
the highest transgene expression happens in 1:20-1:25 DNA:Ploymer ratios.
To make sure that the transgene expression data is accurate, cytotoxicity of each
polyplex, was investigated through MTT assay. MTT assay was carried out for each
of the conditions in figures 2.3-2.5 to calculate cell viability. Low viability shows that
the polyplex was too toxic for the cells, resulting in less accurate data. For this study,
cell viabilities more than 70% were considered to give accurate results. In figure 2.6,
cell viability for each condition has been graphed as a reference for figures 2.3-2.5.
As previously discussed, in order to compare gene delivery, the transgene expres-
sion was compared. However, in order to investigate gene delivery more thoroughly,
we can compare the cellular uptake of different polyplexes by measuring the size
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and zeta potential of all the polyplexes. As discussed before in sections 1.1 and 1.2,
smaller hydrodynamic diameter and higher (more positive) zeta potential can facil-
itate cellular uptake, hence the delivery of the transgene. However, we know that
the relationship between hydrodynamic diameter, zeta potential and gene delivery
efficacy is not always that simple. For example, as discussed in section 1.2, cellular
uptake may be different in a cell line depending on the particle, or as much as positive
zeta potential is beneficial for cellular uptake, before entering the nucleus, polymer
and plasmid must be able to unbind and overly positive zeta potential may make this
stage a bit harder.
Figures 2.7a, 2.8a and 2.9a show the hydrodynamic diameter for each polyplex. As
visible in these figures, DH5α has the lowest diameter in comparison to the other two
in all conditions which correlates with trends in figures 2.3-2.4 showing that smaller
nanoparticles have better chance of cellular uptake and delivery. Also, the smallest
size for all the polyplexes is happening around 1:20-1:25 ratio which correlates with
the peak of transgene expression inprevious transgene expression data in 2.3-2.4.
Similarly for zeta potential, figures 2.7b, 2.8b and 2.9b demonstrate the zeta
potential for each polyplex. These figures demonstrate that DH5α has the most
positive zeta potential in comparison to the other two plasmids in all conditions
which again correlates to the trends we had in figures 2.3-2.4 for transgene delivery.
Also, the most positive zeta potential is in ratios 1:20-1:25 which correlates to the
peaks in 2.3-2.4.
Furthermore, size and zeta potential of the polymers and plasmids themselves
were measured using DLS for comparison with polyplex data. ?? show zeta potential
values for each plasmid at 75 ng
µl
. These data, show the boundaries for previous size
and zeta potential measurements in 2.7-??. We can see in 2.11 the methylated plasmid
has the biggest size and the most positive zeta potential due to the attachment of the
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methyl groups.
In addition to size and zeta potential, other factors may contribute to the trends
and values in figures 2.3-2.4 which correlate to transgene expression. In section 1.3.2,
the effects of Dam and Dcm in prokaryotic gene expression were discussed. Since
adenine and internal cytosine methylation (which is caused by Dam and Dcm) may
enhance the binding of transcription factors and RNA polymerase, hence enhancing
transcription, lacking Dam and Dcm may be a contributing factor that transgene
expression was less in unmethylated plasmids in comparison to the methylated one.
However, this hypothesis must be further examined.
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Chapter 3
CONCLUSION
In conclusion, methylated plasmid had significantly higher efficacy in transgene
delivery and transgene expression in comparison to the two unmethylated plasmids.
This was partially due to the smaller size and more positive zeta potential that poly-
plexes with methylated plasmid. As mentioned in previous section, smaller size and
more positive zeta potential can help the efficacy of cellular uptake. Another hypoth-
esis is that methylation in adenine and internal cytosine also contribute to higher
transgene expression in methylated plasmid. As previously mentioned, methylation
in adenine and internal cytosine can help the binding of DNA and transcription fac-
tors such as RNA polymerase, hence enhance transcription. However, this hypothesis
should be tested in future studies.
In addition, The highest transgene expression was found to be within 1:20-1:25
DNA:Polymer weight ratio in all the conditions.
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